Jane Street Group, LLC Karyopharm Therapeutics Inc. Call Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	BUY	$5.91 - $14.38 $336,870 - $819,660	57,000 Added 42.95%	189,700 $1.4 Million
Q4 2021 Feb 15, 2022	BUY	$5.21 - $8.61 $573,621 - $947,960	110,100 Added 487.17%	132,700 $853,000
Q3 2021 Nov 16, 2021	BUY	$4.45 - $10.63 $30,705 - $73,347	6,900 Added 43.95%	22,600 $132,000
Q2 2021 Aug 16, 2021	SELL	$8.11 - $11.11 $455,781 - $624,382	-56,200 Reduced 78.16%	15,700 $162,000
Q4 2020 Feb 17, 2021	BUY	$14.15 - $17.19 $711,745 - $864,657	50,300 Added 232.87%	71,900 $1.11 Million
Q3 2020 Nov 17, 2020	SELL	$14.14 - $19.71 $1.54 Million - $2.15 Million	-109,200 Reduced 83.49%	21,600 $315,000
Q2 2020 Aug 17, 2020	SELL	$16.6 - $25.25 $56,440 - $85,850	-3,400 Reduced 2.53%	130,800 $2.48 Million
Q1 2020 May 15, 2020	BUY	$14.38 - $27.72 $1.93 Million - $3.72 Million	134,200 New	134,200 $2.58 Million

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $67M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.